The document outlines a prompt designed to evaluate the capabilities of a language model (LLM) in science question answering. The prompt instructs the model to provide concise answers based on a given context, responding with "Unsure about answer" if uncertain. The context discusses Teplizumab's origins at Ortho Pharmaceutical, highlighting that the antibody OKT3, originally sourced from mice, was approved in 1986 for preventing organ rejection in kidney transplants. An example of the prompt is provided: "What was OKT3 originally sourced from?"